13F filing recap · Q2 2011

What did Abrams Capital Management buy in Q2 2011?

Reported stock-position changes between this filing and the previous one.

Stock value

$956.31M

Positions

Estimated turnover

28.4%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

LAMRLamar Advertising Co/new$76.09Mreported value+2.78M shares RBS-TRoyal Bank of Scotland Group Plc$11.03Mreported value+587.0K shares RBS-MRoyal Bank of Scotland Group Plc$10.32Mreported value+600.0K shares RBS.PRNRoyal Bank of Scotland Group Plc$5.97Mreported value+350.0K shares RYRoyal Bank of Scotland Group Plc$5.46Mreported value+315.8K shares

Reduced positions

ARBArbitron Inc$122.52Mreported value-3.3K shares-0.1%MHFIS&P Global Inc.$42.53Mreported value-507.4K shares-33.3%

Exited positions

LZLubrizol Corp$80.38Mprior reported value-600.0K shares-100.0%IRMIron Mountain Inc$62.46Mprior reported value-2.00M shares-100.0%88163VAE9Teva Pharmaceutical Industries Ltd$6.29Mprior reported value-5.50M shares-100.0%